| Record Information |
| Version |
3.5 |
| Creation Date |
2006-05-22 09:12:44 -0600 |
| Update Date |
2013-02-08 17:12:23 -0700 |
| HMDB ID |
HMDB03252 |
| Secondary Accession Numbers |
|
| Metabolite Identification |
| Common Name |
Thromboxane B2 |
| Description |
Thromboxanes. A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin). -- Pubchem. Thromboxanes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- TXB2
|
| Chemical Formula |
C20H34O6 |
| Average Molecular Weight |
370.4804 |
| Monoisotopic Molecular Weight |
370.23553882 |
| IUPAC Name |
(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoic acid |
| Traditional IUPAC Name |
thromboxane B2 |
| CAS Registry Number |
54397-85-2 |
| SMILES |
CCCCC[C@H](O)\C=C\[C@H]1OC(O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O |
| InChI Identifier |
InChI=1S/C20H34O6/c1-2-3-6-9-15(21)12-13-18-16(17(22)14-20(25)26-18)10-7-4-5-8-11-19(23)24/h4,7,12-13,15-18,20-22,25H,2-3,5-6,8-11,14H2,1H3,(H,23,24)/b7-4-,13-12+/t15-,16-,17-,18+,20?/m0/s1 |
| InChI Key |
XNRNNGPBEPRNAR-JQBLCGNGSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Lipids |
| Class |
Eicosanoids |
| Sub Class |
Thromboxanes |
| Other Descriptors |
- Aliphatic Heteromonocyclic Compounds
- Heterocyclic Fatty Acids
- Organic Compounds
- Unsaturated Fatty Acids
|
| Substituents |
- Allyl Alcohol
- Carboxylic Acid
- Hemiacetal
- Oxane
- Secondary Alcohol
|
| Direct Parent |
Thromboxanes |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Cell signaling
- Fuel and energy storage
- Fuel or energy source
- Membrane integrity/stability
|
| Application |
- Nutrients
- Stabilizers
- Surfactants and Emulsifiers
|
| Cellular locations |
- Extracellular
- Membrane (predicted from logP)
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
Not Available |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
Not Available
|
| Biological Properties |
| Cellular Locations |
- Extracellular
- Membrane (predicted from logP)
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
| Tissue Location |
- Muscle
- Skeletal Muscle
- Bladder
- Neuron
- Pancreas
- Placenta
- Testes
- Epidermis
- Prostate
- Adipose Tissue
- Lung
- Nerve Cells
- Platelet
- Spleen
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.00019 +/- 0.00007 uM |
Adult (>18 years old) |
Female |
Normal |
Concentration in plasma from blood that was...
|
| Blood |
Detected and Quantified |
|
0.00041 +/- 0.00018 uM |
Adult (>18 years old) |
Female |
Normal |
Concentration in plasma from blood that was...
|
| Blood |
Detected and Quantified |
|
0.00554 +/- 0.00235 uM |
Adult (>18 years old) |
Female |
Normal |
Concentration in serum after blood samples were...
|
| Blood |
Detected and Quantified |
|
0.01080 +/- 0.00370 uM |
Adult (>18 years old) |
Female |
Normal |
Concentration in serum after blood samples were...
|
| Blood |
Detected and Quantified |
|
0.48196 +/- 0.14576 uM |
Adult (>18 years old) |
Female |
Normal |
Concentration in serum after blood samples were...
|
| Blood |
Detected and Quantified |
|
0.0214 +/- 0.0409 uM |
Adult (>18 years old) |
Both |
Normal |
Oxygenated lipids were quantified by Theresa L....
|
| Blood |
Detected and Quantified |
|
0.865 +/- 0.18 uM |
Adult (>18 years old) |
Not Specified |
Normal |
HM Replicate Plasma (n=3)
|
| Blood |
Detected and Quantified |
|
0.95 +/- 0.24 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
0.919 +/- 1.6 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Pennington Plasma (n=70)
|
| Blood |
Detected and Quantified |
|
3.7E-5 +/- 7E-6 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.00085 +/- 0.00015 umol/mmol creatinine |
Adult (>18 years old) |
Female |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.0024 +/- 0.00094 umol/mmol creatinine |
Adult (>18 years old) |
Female |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.0526 (0.0395-0.0658) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.027 +/- 0.048 uM |
Adult (>18 years old) |
Both |
Ischemic heart disease |
Patients with osteoarthritis (knee or hip...
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.000267 uM |
Children (1-13 year old) |
Not Specified |
closed head |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.00220 (0.000583-0.00451) uM |
Children (1-13 year old) |
Not Specified |
closed head |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.00264 uM |
Children (1-13 year old) |
Not Specified |
gunshot wound |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.000107 uM |
Not Specified |
Not Specified |
HIV-Seropositive, Dementia |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.000467 +/- 0.000243 uM |
Not Specified |
Not Specified |
hydrocephalus |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.00172 (0.000945-0.00248) uM |
Children (1-13 year old) |
Not Specified |
hypoxic/ischemic |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.00289 (0.000594-0.00711) uM |
Children (1-13 year old) |
Not Specified |
meningitis |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.0117 +/- 0.00177 uM |
Not Specified |
Not Specified |
subarachnoid hemorrhage with cerebral vasospasm |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.0155 +/- 0.00243 uM |
Not Specified |
Not Specified |
subarachnoid hemorrhage without cerebral vasospasm |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
3.322e-05 uM |
Not Specified |
Not Specified |
HIV-Seropositive (Neurologically normal) |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.000032 +/- 0.00001 uM |
Adult (>18 years old) |
Both |
Intracranial tumours |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Brain tumors |
- Walker V, Pickard JD, Smythe PJ, Perry S: Eicosanoid production by brain tumours in vivo--evidence for intracranial compartmentation. J Neurooncol. 1991 Dec;11(3):259-62.
Pubmed: 1823345
|
| Ischemic heart disease |
- Renda G, Tacconelli S, Capone ML, Sacchetta D, Santarelli F, Sciulli MG, Zimarino M, Grana M, D'Amelio E, Zurro M, Price TS, Patrono C, De Caterina R, Patrignani P: Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. Clin Pharmacol Ther. 2006 Sep;80(3):264-74.
Pubmed: 16952493
|
| Normal |
- Farker K, Schweer H, Vollandt R, Nassr N, Nagel U, Seyberth HW, Hoffmann A, Oettel M: Measurements of urinary prostaglandins in young ovulatory women during the menstrual cycle and in postmenopausal women. Prostaglandins. 1997 Sep;54(3):655-64.
Pubmed: 9373880
- Viinikka L, Ylikorkala O: Measurement of thromboxane B2 in human plasma or serum by radioimmunoassay. Prostaglandins. 1980 Oct;20(4):759-66.
Pubmed: 7465865
|
|
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB023130 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
4446261  |
| KEGG Compound ID |
C05963  |
| BioCyc ID |
Not Available |
| BiGG ID |
Not Available |
| Wikipedia Link |
Thromboxane B2  |
| NuGOwiki Link |
HMDB03252  |
| Metagene Link |
HMDB03252  |
| METLIN ID |
422  |
| PubChem Compound |
5283137  |
| PDB ID |
Not Available |
| ChEBI ID |
28728  |
| References |
| Synthesis Reference |
Not Available |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Janssen PL, Meyboom S, van Staveren WA, de Vegt F, Katan MB: Consumption of ginger (Zingiber officinale roscoe) does not affect ex vivo platelet thromboxane production in humans. Eur J Clin Nutr. 1996 Nov;50(11):772-4.
Pubmed: 8933126
- Turi S, Bereczki C, Torday C, Havass Z, Nemeth M: The effects of bicarbonate and acetate haemodialysis on platelet cyclic AMP concentration, thromboxane B2 release and aggregation. Pediatr Nephrol. 1991 May;5(3):327-31.
Pubmed: 1651098
- Vissinger H, Husted SE, Kristensen SD, Nielsen HK: Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid. Angiology. 1993 Aug;44(8):633-8.
Pubmed: 8342880
- Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP, Goldberg DM: Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta. 1996 Mar 15;246(1-2):163-82.
Pubmed: 8814965
- Zahavi M, Zahavi J: Concomitant in vitro platelet hypofunction and increased thromboxane B2 (TXB2) generation and enhanced in vivo platelet activation. A distinct syndrome in thrombosis? Eur J Haematol. 1997 Oct;59(4):266-7.
Pubmed: 9338626
- Nyyssonen K, Seppanen K, Salonen JT: High-performance liquid chromatographic assay of platelet-produced thromboxane B2. J Chromatogr. 1993 Jan 29;612(1):27-32.
Pubmed: 8454699
- Anfossi G, Trovati M, Mularoni E, Massucco P, Cavalot F, Mattiello L, Emanuelli G: Effects of diltiazem on thromboxane B2 production from platelet-rich plasma and whole blood. Prostaglandins Leukot Essent Fatty Acids. 1991 Nov;44(3):149-54.
Pubmed: 1808624
- Laitinen O, Seppala E, Nissila M, Vapaatalo H: Plasma levels and urinary excretion of prostaglandins in patients with rheumatoid arthritis. Clin Rheumatol. 1983 Dec;2(4):401-6.
Pubmed: 6589104
- Fuse S, Tomita H, Chiba S: Plasma thromboxane B2 concentration in patients with ventricular septal defect and pulmonary hypertension. Jpn Circ J. 1998 Mar;62(3):193-7.
Pubmed: 9583446
- Tewes KS, Tsikas D, Gutzki FM, Frolich JC: Measurement of thromboxane B2 in platelet-rich human plasma by gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry following extractive pentafluorobenzyl esterification. Anal Biochem. 1998 Jul 15;261(1):121-4.
Pubmed: 9683522
- de Meijer A, Vollaard H, de Metz M, Verbruggen B, Thomas C, Novakova I: Meloxicam, 15 mg/day, spares platelet function in healthy volunteers. Clin Pharmacol Ther. 1999 Oct;66(4):425-30.
Pubmed: 10546927
- Mistakopulo NF, Shoshiashvili VD, Saltanov AI, Kushlinskii NE, Ivshina AV, Madzhuga AI, Liakina LT, Ukrainets AM, Zabotina TN, Kadagidze ZG: [The effect of indomethacin and leukinferon on the level of blood plasma thromboxane B2, platelet aggregation and the immune system of patients with endometrial cancer in the perioperative period] Anesteziol Reanimatol. 1992 Mar-Apr;(2):14-8.
Pubmed: 1416192
- Fuse S, Kamiya T: Plasma thromboxane B2 concentration in pulmonary hypertension associated with congenital heart disease. Circulation. 1994 Dec;90(6):2952-5.
Pubmed: 7994842
|